U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
167761167761Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedHas ResultsHypertensionDrug: Azilsartan Medoxomil|Drug: Azilsartan Medoxomil|Drug: Azilsartan Medoxomil|Drug: Azilsartan Medoxomil|Drug: Azilsartan Medoxomil|Drug: Olmesartan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00362115
167762167762A Phase II Study of Cetuximab Plus Irinotecan in Patients With EGFR-detectable Metastatic Colorectal CarcinomaCompletedNo Results AvailableColorectal CarcinomaDrug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00362102
167763167763Fatty Acids During Pregnancy and Lactation and Body Fat Mass in NewbornsCompletedNo Results AvailableOverweight|ObesityDietary Supplement: Marinol D-40https://ClinicalTrials.gov/show/NCT00362089
167764167764The Role of Motion in Infants' Ability to CategorizeCompletedNo Results AvailableChild Developmenthttps://ClinicalTrials.gov/show/NCT00362076
167765167765Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone DeficiencyRecruitingNo Results AvailableGrowth Hormone DeficiencyDrug: growth hormone (Nutropin)https://ClinicalTrials.gov/show/NCT00362063
167766167766RBx11160 Phase II Dose Ranging Study RBx/MMV05-06CompletedNo Results AvailablePlasmodium Falciparum MalariaDrug: Treatment with 3 dose groups of RBx11160 over 7 dayshttps://ClinicalTrials.gov/show/NCT00362050
167767167767I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular HypertrophyCompletedNo Results AvailableHypertensionDrug: Irbesartan (Aprovel)https://ClinicalTrials.gov/show/NCT00362037
167768167768MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED)CompletedNo Results AvailableAlzheimer's DiseaseDrug: MK0952|Drug: Comparator: Placebohttps://ClinicalTrials.gov/show/NCT00362024
167769167769Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesBehavioral: Salba diethttps://ClinicalTrials.gov/show/NCT00362011
167770167770Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated CystitisWithdrawnNo Results AvailableCystitisDrug: NITROFURANTOIN MACROCRYSTALShttps://ClinicalTrials.gov/show/NCT00361998
167771167771Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass SurgeryWithdrawnNo Results AvailableAnastomotic Stricture|Morbid ObesityDrug: Esomeprazole|Drug: Esomeprazolehttps://ClinicalTrials.gov/show/NCT00361985
167772167772Elucidation of Acid-Induced Pulmonary InflammationCompletedNo Results AvailableGastroesophageal Reflux|AsthmaDrug: lansoprazole|Drug: placebohttps://ClinicalTrials.gov/show/NCT00361972
167773167773SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseCompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Tiotropium bromide 18mcg|Drug: Fluticasone propionate/ salmeterol combination 50/500mcghttps://ClinicalTrials.gov/show/NCT00361959
167774167774The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).RecruitingNo Results AvailableType 2 Diabeteshttps://ClinicalTrials.gov/show/NCT00361946
167775167775Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's DiseaseWithdrawnNo Results AvailableGiant Lymph Node HyperplasiaDrug: Valganciclovirhttps://ClinicalTrials.gov/show/NCT00361933
167776167776Cell Biology of Steroid Resistant AsthmaCompletedNo Results AvailableAsthmaDrug: prednisonehttps://ClinicalTrials.gov/show/NCT00361920
167777167777Effect of Pulsatile IV Insulin on Circulating Risk Markers of Vascular and Metabolic Complications in Pts With DiabetesTerminatedNo Results AvailableDiabetes MellitusProcedure: Effect of Pulsatile IV insulin on diabetic pt blood markers|Procedure: Effect of Pulsatile IV Insulin on blood markers|Procedure: Effect of Pulsatile IV insulin on diabetic pt blood markershttps://ClinicalTrials.gov/show/NCT00361907
167778167778Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE). A Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement.CompletedNo Results AvailablePrevention|Venous ThromboembolismDrug: Rivaroxaban (BAY59-7939)|Drug: Enoxaparinhttps://ClinicalTrials.gov/show/NCT00361894
167779167779Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex LabialisCompletedNo Results AvailableHerpes LabialisDrug: ME-609|Drug: acyclovir in ME-609 vehicle|Drug: Vehiclehttps://ClinicalTrials.gov/show/NCT00361881
167780167780Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITerminatedNo Results AvailableDyslipidemia|Glucose Metabolism DisorderDrug: fenofibrate (F) + metformin (M) hydrochloride fixed combination|Drug: Rosiglitazonehttps://ClinicalTrials.gov/show/NCT00361868
167781167781Safety Study of Bone Marrow Derived Cells to Treat Damaged Heart MuscleCompletedNo Results AvailableMyocardial InfarctionDrug: NX-CP105https://ClinicalTrials.gov/show/NCT00361855
167782167782Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal CancerCompletedNo Results AvailableColorectal NeoplasmsDrug: CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injectionhttps://ClinicalTrials.gov/show/NCT00361842
167783167783The Influence of Maternal Age, Employment Status, and Parenthood Status on Children's Cognitive DevelopmentActive, not recruitingNo Results AvailableChild Developmenthttps://ClinicalTrials.gov/show/NCT00361829
167784167784Human MATER and Idiopathic InfertilityCompletedNo Results AvailableInfertilityhttps://ClinicalTrials.gov/show/NCT00361816
167785167785Topotecan Pharmacokinetic Characterization StudyCompletedNo Results AvailableMalignancy|Solid Tumor Cancer|CancerDrug: topotecanhttps://ClinicalTrials.gov/show/NCT00361803
167786167786Aripiprazole and Lexapro Drug Interaction StudyCompletedNo Results AvailableHealthyDrug: Escitalopram on days -7 to day 14; Aripiprazole dosed starting Day 1 to day 14: 3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mghttps://ClinicalTrials.gov/show/NCT00361790
167787167787Diagnostic Performance of Screening Tests for Cushing s SyndromeActive, not recruitingNo Results AvailableCushing's Syndromehttps://ClinicalTrials.gov/show/NCT00361777
167788167788Substrate Cycling in Energy MetabolismCompletedNo Results AvailableBurns|Insulin ResistanceDrug: fenofibratehttps://ClinicalTrials.gov/show/NCT00361751
167789167789Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin TreatmentCompletedNo Results AvailableType 2 Diabetes MellitusDrug: AVE2268https://ClinicalTrials.gov/show/NCT00361738
167790167790Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ FailureTerminatedNo Results AvailableSevere Sepsis|Organ Failurehttps://ClinicalTrials.gov/show/NCT00361725

* Görseller ve İçerik tekif hakkına sahip olabilir